GLPwatch
Dulaglutide vs Mazdutide
Molecule comparison
Last updated 2026-05-28 15:46 UTCDulaglutide (brand name Trulicity) is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes and reduce cardiovascular risk; it is injected weekly. Mazdutide, still in development, is a dual GLP-1 and glucagon receptor agonist that has not yet been approved for any use.
AI summary of the sources below.
| Dulaglutide | Mazdutide | |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | GLP-1 and glucagon receptor dual agonist |
| Status | Approved | Pipeline |
| Branded products | trulicity | — |
Compare full details on the Dulaglutide and Mazdutide pages.